[{"address1": "10 Carlson Court", "address2": "Suite 701", "city": "Etobicoke", "state": "ON", "zip": "M9W 6L2", "country": "Canada", "phone": "647 495 9000", "fax": "416 213 0045", "website": "https://www.hlstherapeutics.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.", "fullTimeEmployees": 91, "companyOfficers": [{"maxAge": 1, "name": "Mr. Craig Stuart Millian M.B.A.", "age": 55, "title": "CEO & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 700327, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Hanna CPA, CGA, M.B.A.", "age": 58, "title": "Interim CFO & Non-Independent Director", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 31484, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jason A. Gross Pharm.D.", "age": 58, "title": "Vice President of Scientific Affairs", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 269019, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan C. Lennox B.A., J.D.", "age": 42, "title": "Senior VP of Legal, HR & Compliance and Corporate Secretary", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 322835, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian T. Walsh", "title": "Senior Vice President of Commercial", "fiscalYear": 2023, "totalPay": 342219, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Spence", "age": 55, "title": "VP & Corporate Controller", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 5, "shareHolderRightsRisk": 5, "overallRisk": 6, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.34, "open": 2.34, "dayLow": 2.34, "dayHigh": 2.34, "regularMarketPreviousClose": 2.34, "regularMarketOpen": 2.34, "regularMarketDayLow": 2.34, "regularMarketDayHigh": 2.34, "dividendRate": 0.15, "dividendYield": 0.0421, "exDividendDate": 1682553600, "fiveYearAvgDividendYield": 1.7, "beta": 1.043, "volume": 300, "regularMarketVolume": 300, "averageVolume": 19, "averageVolume10days": 30, "averageDailyVolume10Day": 30, "bid": 2.25, "ask": 2.47, "bidSize": 40000, "askSize": 40000, "marketCap": 75346824, "fiftyTwoWeekLow": 2.22, "fiftyTwoWeekHigh": 4.0, "priceToSalesTrailing12Months": 1.2794068, "fiftyDayAverage": 2.4328, "twoHundredDayAverage": 3.0090084, "currency": "USD", "enterpriseValue": 124950728, "profitMargins": -0.40905, "floatShares": 16238299, "sharesOutstanding": 31793000, "heldPercentInsiders": 0.00373, "heldPercentInstitutions": 0.65203005, "bookValue": 2.601, "priceToBook": 0.8996539, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -24090000, "trailingEps": -0.75, "enterpriseToRevenue": 2.122, "enterpriseToEbitda": 7.221, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "HLTRF", "underlyingSymbol": "HLTRF", "shortName": "HLS Therapeutics Inc.", "longName": "HLS Therapeutics Inc.", "firstTradeDateEpochUtc": 1264602600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "eccb6bcb-a58b-3a5d-a5ed-c2a2951dfce3", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.34, "recommendationKey": "none", "totalCash": 32515000, "totalCashPerShare": 1.023, "ebitda": 17304000, "totalDebt": 83070000, "quickRatio": 1.597, "currentRatio": 2.024, "totalRevenue": 58892000, "debtToEquity": 100.44, "revenuePerShare": 1.839, "returnOnAssets": -0.028870001, "returnOnEquity": -0.24816999, "freeCashflow": 20994000, "operatingCashflow": 12398000, "revenueGrowth": -0.116, "grossMargins": 0.75844, "ebitdaMargins": 0.29383, "operatingMargins": -0.13947, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]